Related Experiment Video
Updated: Oct 23, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to
Rahaba Marima1,2, Rodney Hull1, Zodwa Dlamini1
1SAMRC/UP Precision Prevention and Novel Drug Targets for HIV-Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa.
Abstract:
The profiling and identification of genes that are differentially expressed is frequently used to underpin the underlying molecular mechanisms of biological conditions and provides a molecular foothold on biological questions of interest. However, this can be a daunting task since there is a cross talk and overlap of some of the components of the signalling pathways. The deregulation of the cell cycle signalling pathway is a hallmark of cancer, including lung cancer. Proper regulation of the cell cycle results in cellular homeostasis between cell proliferation and cell death. The comprehension of the cell cycle regulation in drug metabolism studies is of significance. This study aimed at elucidating the regulation of cell cycle genes' in response to LPV/r in lung cells. Thus, this study describes methodology for revealing molecular mechanisms employed by LPV/r to induce stress on genomic DNA. This approach is based on the interrogation of a panel of 84 genes related to the cell cycle pathway, and how the differentially expressed genes' expression pattern corroborates loss in nuclear integrity (phenotypic observation). MAD2L2, AURKB and CASP3 gene expressions were further confirmed by RT-qPCR. Furthermore, the use of in-silico bioinformatics tools integrates the molecular profiles and phenotypic changes. This approach revealed the activation of the DNA damage response (DDR) pathway in response to LPV/r treatment. The proposed methodology will aid in the comprehension of drug metabolism at genotypic and phenotypic levels.•Gene profiling often reveals the underlying molecular mechanisms.•RT2 PCR gene arrays have integrated patented quality controls and allow reliable gene expression analysis.•In-silico bioinformatics analysis help reveal pathways affected, that often correspond to phenotypic changes/features.
Insights
This study investigated how Lopinavir/ritonavir (LPV/r) affects cell cycle genes in lung cells. It revealed LPV/r activates the DNA damage response pathway, impacting genomic DNA and nuclear integrity.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Gene expression profiling identifies molecular mechanisms in biological conditions.
- Cell cycle deregulation is a hallmark of cancer, including lung cancer.
- Understanding cell cycle regulation is crucial for drug metabolism studies.
Purpose of the Study:
- To elucidate cell cycle gene regulation in response to Lopinavir/ritonavir (LPV/r) in lung cells.
- To describe a methodology for revealing molecular mechanisms of LPV/r-induced genomic DNA stress.
- To integrate molecular profiles with phenotypic changes using bioinformatics.
Main Methods:
- Interrogation of an 84-gene cell cycle pathway panel.
- Confirmation of specific gene expressions (MAD2L2, AURKB, CASP3) using RT-qPCR.
- Application of in-silico bioinformatics tools for integrated analysis.
Main Results:
- Differential gene expression patterns were observed in response to LPV/r.
- Correlation between gene expression and loss in nuclear integrity (phenotypic observation).
- Activation of the DNA damage response (DDR) pathway was revealed.
Conclusions:
- The study provides a methodology to understand drug metabolism at genotypic and phenotypic levels.
- LPV/r treatment activates the DNA damage response pathway in lung cells.
- Integrated molecular and phenotypic analysis aids in comprehending drug-induced cellular stress.

